Eli Lilly and Company - Search News

Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world. Much that is thanks to the rise of glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro and Zepbound, which are fueling a new wave of growth for the company.

Insider Monkey on MSN · 3d

Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other counter cyclical and defensive stocks to invest in.

Zacks.com on MSN · 4d

Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month,

22h

Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

1d

Eli Lilly & Co: Maintaining Market Dominance with Orforglipron Amid Competitor Challenges

Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

3d

Eli Lilly urges court to toss $183 mln Medicaid fraud judgment

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

1d

Eli Lilly: I Admit Defeat As I Understated Its Growth Prospects (Upgrade)

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

Eli Lilly requests records of people who took copies of its weight-loss drug

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

3d

Prediction: This Will be Eli Lilly's Next Big Move.

This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped ...

1d

Eli Lilly: A Strong Buy Amidst Obesity Treatment Market Dominance and Expanding Pipeline

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

1d

Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

11d

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...

1d

Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results